Schrodinger Inc (SDGR)
Number of days of payables
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data for Schrodinger Inc's number of days of payables is not provided in the JSON file. Without specific values for the number of days of payables for each reporting period, it is not possible to conduct a detailed and comprehensive analysis of this financial ratio at this time.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
Schrodinger Inc
SDGR
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
18.68
Amphastar P
AMPH
31.10
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
45.00
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
41.51
Catalyst Pharmaceuticals Inc
CPRX
26.83